Exchange: NASDAQ·Updated 11:23 AM EDT
News
all
press releases
Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish
The new entity will be called Phytanix, Inc., and it will combine the two companies’ pipelines focused on stress-related and CNS disorders.
Stocktwits

Advertisement|Remove ads.